Form 8-K Werewolf Therapeutics, For: Feb 04
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street rises on Iran war peace deal hopes, SpaceX's historic debut
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil nears two-month lows on reports of imminent US-Iran peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Werewolf Therapeutics receives Nasdaq deficiency notice for low stock price
February 6, 2026 4:43 PM ESTWerewolf Therapeutics Inc. (NASDAQ: HOWL) received a deficiency letter from Nasdaq on February 4, 2026, notifying the company that its stock price had closed below $1.00 per share for 30 consecutive business days, according to a press release.
The biotechnology company's stock failed to meet Nasdaq's minimum bid price requirement of $1.00 per share for continued listing on the... More
